Grant Details
| Grant Number: | 5R01CA256977-05 Interpret this number |
| Primary Investigator: | Kanwal, Fasiha |
| Organization: | Baylor College Of Medicine |
| Project Title: | Multi-Level Evaluation of Racial/Ethnic Disparities in Liver Disease Outcomes |
| Fiscal Year: | 2025 |
Abstract
ABSTRACT Cirrhosis – the end-stage result of chronic liver disease – is a condition with high morbidity and mortality that is becoming increasingly common. Nearly half of all patients with cirrhosis develop hepatic decompensation including hepatocellular cancer (HCC), with frequent hospitalization within 5 years of cirrhosis diagnosis. Several studies show that these cirrhosis complications disproportionately affect racial/ethnic minorities and persons of low socioeconomic status (SES). But fundamental questions remain unanswered given that only few studies investigated the mechanisms that underlie these disparities. The research proposed here aims to provide actionable information on what to target to reduce cirrhosis prognosis disparities. We will conduct a comprehensive evaluation of multilevel factors hypothesized to play important roles in causing racial/ethnic and SES disparities in three key measures of cirrhosis prognosis: a) hepatic decompensation, including HCC, b) liver-related hospitalization, and c) overall survival. We propose a large, multicenter, racially and socio-economically diverse cohort study of cirrhosis patients enrolled from four healthcare systems; the project will combine information from existing clinical databases, genomic data, and geospatial analyses with patient- and clinician- surveys to provide unparalleled information about the role of individual, interpersonal, and community-level factors in the racial/ethnic and SES disparities in cirrhosis prognosis. The proposed cohort includes representative groups from all racial/ethnic (blacks, Hispanics, Asian-Pacific Islanders) and SES groups. It also spans the full spectrum of disease severity (from compensated to advanced decompensated disease), rather than focusing on a few groups. We will uncover the relative contributions of established (hepatitis C virus, hepatitis B virus) and emerging (obesity, diabetes) etiological risk factors as well as risk behaviors (alcohol use) to cirrhosis prognosis disparities. We will also characterize pathways that contribute to cirrhosis disparities among the high order determinants at the individual (e.g., medical mistrust), interpersonal (e.g., bias), and community (e.g., access to transportation) levels either directly or by affecting etiological or behavioral risk factors. Identification of these root cause mechanisms will identify actionable targets for intervention and policy change. We will also examine a set of genetic single nucleotide polymorphisms using stored sera in a subset of the cohort to understand the role of genetic differences, if any, in explaining racial/ethnic disparities.
Publications
Impact of Social Determinants of Health on Hepatocellular Carcinoma Surveillance Receipt and Early Detection.
Authors: Al-Hasan M. , Rich N.E. , Yekkaluri S. , Jones P.D. , Yopp A. , Singal A.G. , ME-HCC Investigators .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2026 Aug; 24(8), p. 2318-2320.
EPub date: 2025-10-10 00:00:00.0.
PMID: 41076044
Related Citations
Causes of mortality among patients with early-stage hepatocellular carcinoma.
Authors: Seif El Dahan K. , Daher D. , Rich N.E. , Nayak A.J. , Ankoma-Sey C. , Govalan R. , Bhongade M.B. , Molina E. , Amador E. , Pitts H. , et al. .
Source: Hepatology (baltimore, Md.), 2026-06-01 00:00:00.0; 83(6), p. 1446-1455.
EPub date: 2025-07-22 00:00:00.0.
PMID: 40694813
Related Citations
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma.
Authors: Choi G.H. , Kim H.S. , Luu M. , Kuo A. , Ayoub W.S. , Trivedi H. , Wang Y. , Vipani A. , Chen P.J. , Miles S.A. , et al. .
Source: Liver Cancer, 2026 May; 15(2), p. 193-204.
EPub date: 2025-07-24 00:00:00.0.
PMID: 41063730
Related Citations
Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium.
Authors: Kanwal F. , Feng Z. , Hoshida Y. , Chhatwal J. , Wong V.W. , Ioannou G.N. , Nahon P. , Lotter W. , Ning J. , Taouli B. , et al. .
Source: Hepatology (baltimore, Md.), 2026-04-20 00:00:00.0; , .
EPub date: 2026-04-20 00:00:00.0.
PMID: 42008824
Related Citations
Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis.
Authors: Rezaee-Zavareh M.S. , Karimi-Sari H. , Parhizkar Roudsari P. , Khattab O. , Attia A.M. , Danpanichkul P. , Hwang S.Y. , Liu J.S. , Yalda T. , Chen P.J. , et al. .
Source: The American Journal Of Gastroenterology, 2026-02-12 00:00:00.0; , .
EPub date: 2026-02-12 00:00:00.0.
PMID: 41677135
Related Citations
Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.
Authors: Kanwal F. , Lopez C. , Ning J. , Luster M. , Reddy K.R. , Parikh N.D. , Singal A.G. , Marrero J.A. , Chhatwal J. , Feng Z. , et al. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2026-02-09 00:00:00.0; , .
EPub date: 2026-02-09 00:00:00.0.
PMID: 41672261
Related Citations
Reply to "Interpreting projected gastrointestinal cancer burden in Africa: The case of liver cancer".
Authors: Danpanichkul P. , Wallace M.B. , Singal A.G. , Yang J.D. .
Source: Cancer, 2026-02-01 00:00:00.0; 132(3), p. e70297.
PMID: 41627077
Related Citations
Reply to "Interpreting projected gastrointestinal cancer burden in Africa: The case of liver cancer".
Authors: Danpanichkul P. , Wallace M.B. , Singal A.G. , Yang J.D. .
Source: Cancer, 2026-02-01 00:00:00.0; 132(3), p. e70297.
PMID: 41627077
Related Citations
Treatment Delays and Survival in Patients With Hepatocellular Carcinoma: A Multicenter Cohort Study.
Authors: Jarrah M. , Rich N.E. , Figueroa G. , Garces S.M. , Al-Hasan M. , Quirk L. , Yekkaluri S. , Terrell J. , Pitts H. , Syeda S. , et al. .
Source: The American Journal Of Gastroenterology, 2026-01-21 00:00:00.0; , .
EPub date: 2026-01-21 00:00:00.0.
PMID: 41562446
Related Citations
Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries.
Authors: Danpanichkul P. , Pang Y. , Tothanarungroj P. , Dejvajara D. , Kim D. , Saokhieo P. , Suparan K. , Muthiah M.D. , Duangsonk K. , Bernal D.O. , et al. .
Source: Cancer, 2026-01-01 00:00:00.0; 132(1), p. e70245.
PMID: 41468237
Related Citations
Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis.
Authors: Chai W. , Rich N.E. , Liu Y. , Campos J. , Quirk L. , Kramer J.R. , Anyanwu J. , Gibbons A. , Loewy A. , Youssef D. , et al. .
Source: Alimentary Pharmacology & Therapeutics, 2025-12-27 00:00:00.0; , .
EPub date: 2025-12-27 00:00:00.0.
PMID: 41454644
Related Citations
Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.
Authors: Danpanichkul P. , Duangsonk K. , Chen V.L. , Saokhieo P. , Dejvajara D. , Sukphutanan B. , Aboona M.B. , Lopimpisuth C. , Pang Y. , Ibrahim A.F. , et al. .
Source: Hepatology (baltimore, Md.), 2025-11-01 00:00:00.0; 82(5), p. 1274-1286.
EPub date: 2025-02-11 00:00:00.0.
PMID: 39937958
Related Citations
Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma.
Authors: Singal A.G. , Salem R. , Pinato D.J. , Pillai A. .
Source: Gastroenterology, 2025 Sep; 169(4), p. 585-599.
EPub date: 2025-05-02 00:00:00.0.
PMID: 40320088
Related Citations
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.
Authors: Singal A.G. , Quirk L. , Boike J. , Chernyak V. , Feng Z. , Giamarqo G. , Kanwal F. , Ioannou G.N. , Manes S. , Marrero J.A. , et al. .
Source: Hepatology (baltimore, Md.), 2025-09-01 00:00:00.0; 82(3), p. 794-809.
EPub date: 2024-12-18 00:00:00.0.
PMID: 40833999
Related Citations
Racial and Ethnic Disparities in Survival Among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-Analysis.
Authors: Shubin A.D. , Leff P.J. , Tadros M.M. , Hsieh M.L. , Hsiehchen D. , Vagefi P.A. , Wang J.Y. , Sapisochin G. , Yopp A.C. , Sanford N.N. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2025-07-30 00:00:00.0; , .
EPub date: 2025-07-30 00:00:00.0.
PMID: 40736454
Related Citations
Racial and ethnic differences in social determinants of health among patients with HCC.
Authors: Al-Hasan M. , Rich N.E. , Figueroa G. , Garces S.M. , Quirk L. , Yekkaluri S. , Yopp A. , Jones P.D. , Singal A.G. .
Source: Hepatology Communications, 2025-07-01 00:00:00.0; 9(7), .
EPub date: 2025-06-09 00:00:00.0.
PMID: 40489762
Related Citations
Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Authors: Hwang S.Y. , Rezaee-Zavareh M.S. , Attia A.M. , Kaymen E.A. , Tran N. , Abou-Alfa G.K. , Parikh N.D. , Singal A.G. , Yang J.D. .
Source: The American Journal Of Gastroenterology, 2025-05-16 00:00:00.0; , .
EPub date: 2025-05-16 00:00:00.0.
PMID: 40377239
Related Citations
Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study.
Authors: Singal A.G. , Yang J.D. , Jalal P.K. , Salgia R. , Mehta N. , Hoteit M.A. , Kao K. , Daher D. , El Dahan K.S. , Hernandez P. , et al. .
Source: The American Journal Of Gastroenterology, 2025-04-23 00:00:00.0; , .
EPub date: 2025-04-23 00:00:00.0.
PMID: 40267274
Related Citations
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation.
Authors: Ahn J.C. , Ng W.H. , Yeo Y.H. , Kim H.S. , Wang Y. , Trivedi H. , Ayoub W.S. , Kuo A. , Rich N. , Parikh N.D. , et al. .
Source: Hepatology (baltimore, Md.), 2025-03-28 00:00:00.0; , .
EPub date: 2025-03-28 00:00:00.0.
PMID: 40153442
Related Citations
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.
Authors: Li P.J. , Tabrizian P. , Daher D. , Gaviria F. , Ajmera V. , Montalvan-Sanchez E.E. , Gutierrez J.A. , Zhou K. , Delebecque F. , Garcia N. , et al. .
Source: Hepatology (baltimore, Md.), 2025-03-11 00:00:00.0; , .
EPub date: 2025-03-11 00:00:00.0.
PMID: 40067686
Related Citations
Inequalities in developing cirrhosis complications over time: A cohort study.
Authors: Cholankeril G. , Taylor T. , Kramer J.R. , Liu Y. , Hernaez R. , Patidar K.R. , Flores A. , Lee T.H. , Rana A. , Samuel R. , et al. .
Source: The American Journal Of Gastroenterology, 2025-02-05 00:00:00.0; , .
EPub date: 2025-02-05 00:00:00.0.
PMID: 39907257
Related Citations
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.
Authors: Hwang S.Y. , Danpanichkul P. , Agopian V. , Mehta N. , Parikh N.D. , Abou-Alfa G.K. , Singal A.G. , Yang J.D. .
Source: Clinical And Molecular Hepatology, 2025 Feb; 31(Suppl), p. S228-S254.
EPub date: 2024-12-26 00:00:00.0.
PMID: 39722614
Related Citations
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.
Authors: Suzuki H. , Fujiwara N. , Singal A.G. , Baumert T.F. , Chung R.T. , Kawaguchi T. , Hoshida Y. .
Source: Hepatology (baltimore, Md.), 2025-01-14 00:00:00.0; , .
EPub date: 2025-01-14 00:00:00.0.
PMID: 39808821
Related Citations
Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.
Authors: Danpanichkul P. , Duangsonk K. , Kalligeros M. , Fallon M.B. , Vuthithammee C. , Pan C.W. , Saokhieo P. , Derrick W. , Pang Y. , Chen V.L. , et al. .
Source: Alimentary Pharmacology & Therapeutics, 2025-01-05 00:00:00.0; , .
EPub date: 2025-01-05 00:00:00.0.
PMID: 39757456
Related Citations
Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors.
Authors: Patel S. , Khalili M. , Singal A.G. , Pinheiro P.S. , Jones P.D. , Kim R.G. , Kode V. , Thiemann A. , Zhang W. , Cheung R. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-12-05 00:00:00.0; , .
EPub date: 2024-12-05 00:00:00.0.
PMID: 39636161
Related Citations
Impact of racial, ethnic, and socioeconomic disparities on presentation and survival of HCC: A multicenter study.
Authors: Rich N.E. , Jones P.D. , Zhu H. , Prasad T. , Hughes A. , Pruitt S. , Murphy C.C. , Seif-El-Dahan K. , Daher D. , Figueroa G. , et al. .
Source: Hepatology Communications, 2024-11-01 00:00:00.0; 8(11), .
EPub date: 2024-10-10 00:00:00.0.
PMID: 39666898
Related Citations
The Prognostic Significance of Nativity, Enclave Residence, and Socioeconomic Status Among Hispanic Patients with Hepatocellular Carcinoma.
Authors: Whitham Z.A. , Nevarez N.M. , Rong R. , Chang G. , Ethun C.G. , Porembka M.R. , Mansour J.C. , Wang S.C. , Polanco P.M. , Zeh H.J. , et al. .
Source: Annals Of Surgical Oncology, 2024-09-21 00:00:00.0; , .
EPub date: 2024-09-21 00:00:00.0.
PMID: 39306623
Related Citations
PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk.
Authors: Thrift A.P. , Kanwal F. , Lim H. , Duong H. , Liu Y. , Singal A.G. , Khaderi S. , Asrani S.K. , Amos C.I. , El-Serag H.B. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2024 Sep; 22(9), p. 1858-1866.e4.
EPub date: 2024-05-09 00:00:00.0.
PMID: 38729396
Related Citations
In utero exposure to antihistamines and risk of hepatocellular carcinoma in a multigenerational cohort.
Authors: Murphy C.C. , Seif El Dahan K. , Singal A.G. , Cirillo P.M. , Krigbaum N.Y. , Cohn B.A. .
Source: Hepatology Communications, 2024-08-01 00:00:00.0; 8(8), .
EPub date: 2024-07-22 00:00:00.0.
PMID: 39037384
Related Citations
Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea".
Authors: Cholankeril G. , Kanwal F. .
Source: Journal Of Hepatology, 2024 May; 80(5), p. e218-e219.
EPub date: 2024-02-01 00:00:00.0.
PMID: 38309438
Related Citations
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.
Authors: Kanwal F. , Neuschwander-Tetri B.A. , Loomba R. , Rinella M.E. .
Source: Hepatology (baltimore, Md.), 2024-05-01 00:00:00.0; 79(5), p. 1212-1219.
EPub date: 2023-11-09 00:00:00.0.
PMID: 38445559
Related Citations
Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.
Authors: Wong R.J. , Jones P.D. , Niu B. , Therapondos G. , Thamer M. , Kshirsagar O. , Zhang Y. , Pinheiro P. , Kyalwazi B. , Fass R. , et al. .
Source: Jama Network Open, 2024-05-01 00:00:00.0; 7(5), p. e2411076.
EPub date: 2024-05-01 00:00:00.0.
PMID: 38743424
Related Citations
Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
Authors: Anouti A. , Seif El Dahan K. , Rich N.E. , Louissaint J. , Lee W.M. , Lieber S.R. , Arab J.P. , Zhang B.Y. , Patel M.J. , Thimphittaya C. , et al. .
Source: Hepatology Communications, 2024-04-01 00:00:00.0; 8(4), .
EPub date: 2024-03-18 00:00:00.0.
PMID: 38497931
Related Citations
Brief alcohol interventions are underutilized in persons with nonalcohol-associated chronic liver diseases.
Authors: Louissaint J. , Melendez-Torres J. , Zhang W. , Kozlitina J. , Anouti A. , Patel M.J. , Zhang B.Y. , Singal A.G. , Mitchell M.C. , Cotter T.G. .
Source: Hepatology Communications, 2024-04-01 00:00:00.0; 8(4), .
EPub date: 2024-04-03 00:00:00.0.
PMID: 38563583
Related Citations
Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Authors: Wagle N.S. , Park S. , Washburn D. , Ohsfeldt R. , Kum H.C. , Singal A.G. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-01-22 00:00:00.0; , .
EPub date: 2024-01-22 00:00:00.0.
PMID: 38252039
Related Citations
Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
Authors: Cotter T.G. , Mitchell M.C. , Patel M.J. , Anouti A. , Lieber S.R. , Rich N.E. , Arab J.P. , Díaz L.A. , Louissaint J. , Kerr T. , et al. .
Source: Transplantation, 2024-01-01 00:00:00.0; 108(1), p. 225-234.
EPub date: 2023-06-21 00:00:00.0.
PMID: 37340542
Related Citations
Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
Authors: Anouti A. , Patel M.S. , VanWagner L.B. , Lee W.M. , Asrani S.K. , Mufti A.R. , Rich N.E. , Vagefi P.A. , Shah J.A. , Kerr T.A. , et al. .
Source: Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society, 2024-01-01 00:00:00.0; 30(1), p. 72-82.
EPub date: 2023-07-26 00:00:00.0.
PMID: 37490432
Related Citations
Evaluating dynamic and predictive discrimination for recurrent event models: use of a time-dependent C-index.
Authors: Wang J. , Jiang X. , Ning J. .
Source: Biostatistics (oxford, England), 2023-11-10 00:00:00.0; , .
EPub date: 2023-11-10 00:00:00.0.
PMID: 37952117
Related Citations
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Authors: Joerg V. , Scheiner B. , D Alessio A. , Fulgenzi C.A.M. , Schönlein M. , Kocheise L. , Lohse A.W. , Huber S. , Wege H. , Kaseb A. , et al. .
Source: Hepatology Communications, 2023-11-01 00:00:00.0; 7(11), .
EPub date: 2023-10-27 00:00:00.0.
PMID: 37889520
Related Citations
Pandemic-related changes in incidence and mortality rates of gastrointestinal cancers during 2020.
Authors: Murphy C.C. , Tavakkoli A. , Wani S. , Singal A.G. .
Source: The American Journal Of Gastroenterology, 2023-10-04 00:00:00.0; , .
EPub date: 2023-10-04 00:00:00.0.
PMID: 37791616
Related Citations
Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy.
Authors: Shaikh A. , Lee T.H. , Rich N.E. , Benhammou J.N. , Lymberopoulos P. , Agopian V.G. , Kim D. , Ahmed A. , Hernaez R. , Berg C.L. , et al. .
Source: Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society, 2023-10-01 00:00:00.0; 29(10), p. 1138-1142.
EPub date: 2023-05-03 00:00:00.0.
PMID: 37129867
Related Citations
Biliary atresia and liver transplantation in the United States: A contemporary analysis.
Authors: Anouti A. , Patel M.S. , VanWagner L.B. , Lee W.M. , Fung J.J. , Cholankeril G. , Hwang C.S. , Mufti A.R. , Tujios S. , Kerr T. , et al. .
Source: Liver International : Official Journal Of The International Association For The Study Of The Liver, 2023 Oct; 43(10), p. 2198-2209.
EPub date: 2023-08-07 00:00:00.0.
PMID: 37548078
Related Citations
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
Authors: Shaikh A. , Goli K. , Lee T.H. , Rich N.E. , Benhammou J.N. , Keeling S. , Kim D. , Ahmed A. , Goss J. , Rana A. , et al. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2023 Aug; 21(9), p. 2288-2297.e4.
EPub date: 2022-12-12 00:00:00.0.
PMID: 36521738
Related Citations
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities.
Authors: Bhatnagar A. , Prakash S. , Lymberopoulos P. , Goff C. , Shaikh A. , Kim D. , Ahmed A. , Berg C. , Naggie S. , Kanwal F. , et al. .
Source: American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons, 2023 Aug; 23(8), p. 1221-1226.
EPub date: 2023-04-26 00:00:00.0.
PMID: 37116583
Related Citations
Actionable Solutions to Achieve Health Equity in Chronic Liver Disease.
Authors: Jones P.D. , Lai J.C. , Bajaj J.S. , Kanwal F. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2023 Jul; 21(8), p. 1992-2000.
EPub date: 2023-04-13 00:00:00.0.
PMID: 37061105
Related Citations
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.
Authors: Alden S.L. , Lim M. , Kao C. , Shu D. , Singal A.G. , Noonan A. , Griffith P. , Baretti M. , Ho W.J. , Kamel I. , et al. .
Source: Cancer Research Communications, 2023 Jul; 3(7), p. 1312-1317.
EPub date: 2023-07-20 00:00:00.0.
PMID: 37484200
Related Citations
Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus.
Authors: Patel A.A. , Tapper E.B. , Kanwal F. , Woodrell C.D. , Hansen L. , Lai J.C. , Rogal S. , McDermott C. , Rakoski M. , Ufere N.N. .
Source: Hepatology Communications, 2023-06-01 00:00:00.0; 7(6), .
EPub date: 2023-06-02 00:00:00.0.
PMID: 37267219
Related Citations
Multidisciplinary care for patients with HCC: a systematic review and meta-analysis.
Authors: Seif El Dahan K. , Reczek A. , Daher D. , Rich N.E. , Yang J.D. , Hsiehchen D. , Zhu H. , Patel M.S. , Bayona Molano M.D.P. , Sanford N. , et al. .
Source: Hepatology Communications, 2023-05-01 00:00:00.0; 7(5), .
EPub date: 2023-04-26 00:00:00.0.
PMID: 37102768
Related Citations
Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening.
Authors: Kolb J.M. , Chen M. , Tavakkoli A. , Gallegos J. , O'Hara J. , Tarter W. , Hochheimer C.J. , Golubski B. , Kopplin N. , Hennessey L. , et al. .
Source: The American Journal Of Gastroenterology, 2023-04-01 00:00:00.0; 118(4), p. 615-626.
EPub date: 2022-10-11 00:00:00.0.
PMID: 36219171
Related Citations
Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Authors: Kassab I. , Singal A.G. , Ali A. , Narasimman M. , Arvind A. , Ahmed M. , Joshi S. , Manzoor K. , Rich N. , Chen V.L. , et al. .
Source: Hepatology Communications, 2023-04-01 00:00:00.0; 7(4), .
EPub date: 2023-03-24 00:00:00.0.
PMID: 36972387
Related Citations